Mizuho analyst Ann Hynes raised the firm’s price target on Pediatrix Medical (MD) to $15 from $13 and keeps a Neutral rating on the shares following the “solid” Q3 report.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD: